Electronic Health Record Clinical Decision Support to Close the Human Papillomavirus Vaccination Gender Disparity in Children Aged 9 and 10 Years

被引:0
作者
Stipelman, Carole H. [1 ,2 ]
Ulibarri, Erica [3 ]
Wilson, Natalie [4 ]
Olivas, Alexis [5 ]
Sanders, Andie [3 ]
Trepman, Elly [6 ,7 ]
Kawamoto, Kensaku [8 ]
机构
[1] Univ Utah, Univ Pediat Clin, Sch Med, Salt Lake City, UT USA
[2] Univ Utah, Sugar House Pediat Clin, Sch Med, Dept Pediat,Div Gen Pediat, Salt Lake City, UT USA
[3] Univ Utah Hlth, Salt Lake City, UT USA
[4] Amer Univ Caribbean, Sch Med, Cupecoy, Sint Maarten
[5] Utah Valley Univ, Orem, UT USA
[6] Univ S Alabama, Frederick P Whiddon Coll Med, Mobile, AL USA
[7] Univ Manitoba, Max Rady Coll Med, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada
[8] Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT USA
关键词
quality improvement; vaccine; boys; prevention; cancer; UPDATED RECOMMENDATIONS; ADVISORY-COMMITTEE; UNITED-STATES; HPV; IMMUNIZATION; ADOLESCENTS;
D O I
10.1177/00099228251324017
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We performed a quality improvement project (31 clinics; July 2021 to October 2023) to increase human papillomavirus vaccination initiation frequency and decrease gender disparity in children aged 9 and 10 years. The 11 process changes included electronic health record clinical decision support (CDS) tools for providers, staff, and parents and medical assistant participation. In phase 1 (preparation), initiation frequency was lower in boys (250 of 1688 visits, 15%) than girls (289 of 1549 visits, 19%; P = .003). In phase 2 (CDS alerts; recommended initiation age lowered from 11 to 9 years), initiation frequency was increased and similar between boys (906 of 1847 visits, 49%) and girls (867 of 1740 visits, 50%; P = .64). In phase 3 (patient portal outreach), initiation frequency was increased further for boys and girls. The multifaceted intervention, including CDS tools and lowering the initiation age, was associated with increased initiation frequency and decreased gender disparity.
引用
收藏
页码:1160 / 1168
页数:9
相关论文
共 42 条
[1]   Trends in Reasons for Human Papillomavirus Vaccine Hesitancy: 2010-2020 [J].
Adjei Boakye, Eric ;
Nair, Mrudula ;
Abouelella, Dina K. ;
Joseph, Christine L. M. ;
Gerend, Mary A. ;
Subramaniam, Divya S. ;
Osazuwa-Peters, Nosayaba .
PEDIATRICS, 2023, 151 (06)
[2]  
Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P630
[3]  
[Anonymous], 2003, CDC
[4]   HPV: WHO calls for countries to suspend vaccination of boys [J].
Arie, Sophie .
BMJ-BRITISH MEDICAL JOURNAL, 2019, 367 :l6765
[5]   Factors Associated With Persistence and Clearance of High-Risk Oral Human Papillomavirus (HPV) Among Participants in the HPV Infection in Men (HIM) Study [J].
Bettampadi, Deepti ;
Sirak, Bradley A. ;
Abrahamsen, Martha E. ;
Reich, Richard R. ;
Villa, Luisa L. ;
Ponce, Eduardo Lazcano ;
Giuliano, Anna R. .
CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) :E3227-E3234
[6]   A quality improvement education initiative to increase adolescent human papillomavirus (HPV) vaccine completion rates [J].
Bonville, Cynthia A. ;
Domachowske, Joseph B. ;
Suryadevara, Manika .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (7-8) :1570-1576
[7]  
Cates JR., 2015, IMPLEMENT SCI, V10, DOI [10.1186/1748-5908-10-S1-A5, DOI 10.1186/1748-5908-10-S1-A5]
[8]  
Centers for Disease Control and Prevention (CDC), CLIN DECISION SUPPOR
[9]   Gender Differences in Knowledge and Attitude towards HPV and HPV Vaccine among College Students in Wenzhou, China [J].
Chen, Gang ;
Wu, Biao ;
Dai, Xuchao ;
Zhang, Mengqi ;
Liu, Yupeng ;
Huang, Hong ;
Mei, Kun ;
Wu, Zhigang .
VACCINES, 2022, 10 (01)
[10]   Worldwide burden of cancer attributable to HPV by site, country and HPV type [J].
de Martel, Catherine ;
Plummer, Martyn ;
Vignat, Jerome ;
Franceschi, Silvia .
INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (04) :664-670